Skip to content

Clinical study on the treatment of amyotrophic lateral sclerosis by applying Wen-Shen-Jian-Pi plaster

Clinical study on the treatment of amyotrophic lateral sclerosis by applying Wen-Shen-Jian-Pi plaster

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102754
Enrollment
Unknown
Registered
2025-05-20
Start date
2023-05-10
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

Interventions

Treatment group:The treatment group was given conventional western medicine and Wen-Shen-Jian-Pi plaster
placebo group:The placebo group was given conventional western medicine treatment and placebo plaster

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clinically, it meets the diagnostic criteria of ALS. 2. Age 20-80 years old, gender is not limited; 3. The duration of the disease within 5 years includes patients who have been treated with gastrostomy and non-invasive ventilators; 4. And the patient or family member has consented to observation and follow-up, and the patient or family member has signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Under 20 years of age or over 80 years of age; 2. Patients with shoulder and back or lumbosacral skin diseases or allergies to skin adhesive patches; 3.Have uncontrolled serious primary diseases of the heart, liver, kidney, hematopoietic system and endocrine system; 4.Other neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, frontotemporal dementia, and people with mental disorders; 5. Pregnant or lactating women; 6. According to the researchers' judgment, patients with poor compliance and high possibility of shedding, such as those who could not take medication on time or could not apply drugs to patients without specialized caregivers; 7.Also participate in other clinical experimenters.

Design outcomes

Primary

MeasureTime frame
ALS Functional Scale (ALSFRS) score;amyotrophic lateral sclerosis symptom score in integrative treatments, ALS-SSIT;

Secondary

MeasureTime frame
Standard of curative effect of TCM syndrome;Laboratory examination;

Countries

China

Contacts

Public ContactWeidong Pan

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

panwd@shutcm.edu.cn+86 135 2498 4956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026